Gilead Sciences Inc. Earnings

Gilead Sciences Inc.’s revenue jumped 2.97% since last year same period to $7769Mn in the Q3 2025. On a quarterly growth basis, Gilead Sciences Inc. has generated 9.72% jump in its revenue since last 3-months.

Gilead Sciences Inc.’s net profit jumped 143.58% since last year same period to $3052Mn in the Q3 2025. On a quarterly growth basis, Gilead Sciences Inc. has generated 55.71% jump in its net profits since last 3-months.

Gilead Sciences Inc.’s net profit margin jumped 136.55% since last year same period to 39.28% in the Q3 2025. On a quarterly growth basis, Gilead Sciences Inc. has generated 41.92% jump in its net profit margins since last 3-months.

Gilead Sciences Inc.’s price-to-earnings ratio after this Q3 2025 earnings stands at 18.78.

Gilead Sciences Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.86 - a -13.49% fall from last quarter’s estimates.

Gilead Sciences Inc.’s earning per share (EPS) estimates for the current year stand at 1.86.

Gilead Sciences Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q4 2025. This indicates that the Gilead Sciences Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Gilead Sciences Inc. declared 0.79 dividend per share during the earnings announcement for Q4 2025.